Recent Searches
Trending
M&A outlook: stronger US deal market in 2026 despite mixed economic signals
28 Oct 2025 GrowthUS Healthcare Cyber Resilience Survey: Why elevating cybersecurity to a strategic priority can drive transformation
03 Nov 2025Beyond cost cutting: AI as the ultimate growth engine
03 Nov 2025 ConsultingDr. Oliver Eitelwein is a partner with EY-Parthenon based in Düsseldorf, Germany in the life science strategy service.
He has more than 17 years of experience in strategy consulting across corporate strategy, supply chain and operations, sustainability, and digital transformation/smart healthcare.
Oliver acts as a trusted strategic advisor on mission-critical issues of the world’s largest pharma, medical device, agriculture and consumer corporations, always striving for measurable impact.
He has published more than 20 studies, management articles and books on strategy, operations, digital, analytics, private equity and finance/controlling.
Oliver earned a master’s degree in engineering (Dipl.-Wi.-Ing.) from the Karlsruhe Institute of Technology and a PhD with distinction in strategic management from WHU – Otto Beisheim School of Management.
